Articles published in Journal of Pharmacovigilance have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacovigilance has got h-index 25, which means every article in Journal of Pharmacovigilance has got 25 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacovigilance.

Journal total citations count 2408
Journal impact factor 1.71
Journal 5 years impact factor 1.79
Journal cite score 12.14
Journal h-index 25
Important citations

Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization

A Large-Scale CNN Ensemble for Medication Safety Analysis

Dependency-based long short term memory network for drug-drug interaction extraction

Drug-drug interaction extraction from biomedical texts using long short-term memory network

Application of Novel Genotyping Microarray Technologies in Cancer Research

A Survey of Network-Based Modelling and Intelligent Data Mining of Social Media for Improving Care

Adverse Drug Event Information Extraction from Medical Narratives using Ensemble Learning & Deep Learning

Novel Antitumor Benefit of Metformin: Beyond Glycemic Control

Real-world data-based adverse drug reactions detection from the Korea Adverse Event Reporting System databases with electronic health records-based detection algorithm

The pivotal relation between glucagon-like peptides, NF?B and inflammatory bowel disease

Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives

Multi-layered Learning for Information Extraction from Adverse Drug Event Narratives

Cardiovascular outcome trials in type 2 diabetes: A critical analysis

Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

One Size Does Not Fit All: An Ensemble Approach Towards Information Extraction from Adverse Drug Event Narratives

Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus

The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis

Adverse Effects of GLP-1 Receptor Agonists

Antidiabetic Activity and Pharmacodynamic Interaction of Combined Administration of Ethanolic Stem Bark Extract of Enantia Chlorantha and Lisinopril in Type 2 Diabetic Rats

Risk of Hypoglycemia After Concomitant Use of Antidiabetic, Antihypertensive, and Antihyperlipidemic Medications: A Database Study